BOLIGNANO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 2.722
AS - Asia 2.314
EU - Europa 1.037
SA - Sud America 616
AF - Africa 73
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 6.773
Nazione #
US - Stati Uniti d'America 2.552
SG - Singapore 1.120
BR - Brasile 500
CN - Cina 468
IT - Italia 433
IN - India 256
VN - Vietnam 249
SE - Svezia 144
DE - Germania 136
CA - Canada 135
GB - Regno Unito 73
HK - Hong Kong 73
FI - Finlandia 63
AR - Argentina 48
NL - Olanda 27
RO - Romania 27
BD - Bangladesh 24
EC - Ecuador 23
RU - Federazione Russa 23
ID - Indonesia 22
MX - Messico 22
ES - Italia 21
FR - Francia 19
PL - Polonia 18
JP - Giappone 17
ZA - Sudafrica 16
UA - Ucraina 13
CL - Cile 12
EG - Egitto 12
IQ - Iraq 12
IR - Iran 12
MA - Marocco 12
CO - Colombia 11
TR - Turchia 11
AT - Austria 10
PK - Pakistan 8
PY - Paraguay 8
AU - Australia 7
TN - Tunisia 7
CZ - Repubblica Ceca 6
SN - Senegal 6
UZ - Uzbekistan 6
VE - Venezuela 6
PE - Perù 5
IL - Israele 4
KE - Kenya 4
LT - Lituania 4
MK - Macedonia 4
TW - Taiwan 4
AO - Angola 3
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
SA - Arabia Saudita 3
TH - Thailandia 3
AZ - Azerbaigian 2
BB - Barbados 2
DK - Danimarca 2
EE - Estonia 2
EU - Europa 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
ML - Mali 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
ZM - Zambia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AQ - Antartide 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
PH - Filippine 1
SC - Seychelles 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
UY - Uruguay 1
YT - Mayotte 1
Totale 6.773
Città #
Singapore 411
Dallas 376
Santa Clara 228
Bengaluru 222
Hefei 222
Chandler 212
Milan 183
Lawrence 171
Princeton 171
Wilmington 117
Ashburn 110
Ottawa 106
Munich 102
Ho Chi Minh City 97
Council Bluffs 88
Hong Kong 71
Beijing 68
São Paulo 53
Boardman 52
Los Angeles 49
Hanoi 45
London 40
Des Moines 38
Turku 38
New York 30
Chicago 28
Helsinki 25
Rome 18
Boston 17
Rio de Janeiro 17
Warsaw 16
San Francisco 15
The Dalles 15
Tokyo 15
Brasília 14
Brooklyn 14
Da Nang 14
Naples 14
Norwalk 13
Redmond 13
Guayaquil 12
Catanzaro 11
Columbus 11
Timisoara 11
Bari 10
Chennai 10
Crotone 10
Guarulhos 10
Seattle 10
Biên Hòa 9
Guangzhou 9
Johannesburg 9
Mexico City 9
Montreal 9
Palermo 9
Phoenix 9
Pune 9
Stockholm 9
Amsterdam 8
Charlotte 8
Shibin al Kawm 8
Ankara 7
Atlanta 7
Haiphong 7
Jakarta 7
Redwood City 7
Thái Bình 7
Ann Arbor 6
Asunción 6
Campinas 6
Dakar 6
Goiânia 6
Hải Dương 6
Ninh Bình 6
Osasco 6
Salvador 6
Santo André 6
São Bernardo do Campo 6
Baghdad 5
Buenos Aires 5
Bình Dương 5
Cosenza 5
Denver 5
Florence 5
Joinville 5
Lamezia Terme 5
Lecce 5
Manchester 5
Nanjing 5
Quito 5
Secaucus 5
Shenzhen 5
Tashkent 5
Vienna 5
Belo Horizonte 4
Betim 4
Canoas 4
Caraguatatuba 4
Copiapó 4
Corigliano Calabro 4
Totale 3.960
Nome #
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study 118
Antecedent ACE-inhibition, inflammatory response, and cardiac surgery associated acute kidney injury 106
Hypoxia-inducible factor stabilizers in end stage kidney disease: “can the promise be kept?” 81
Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial. 75
Altered circulating marinobufagenin levels and recurrent intradialytic hypotensive episodes in chronic hemodialysis patients: a pilot, prospective study 71
A brief "update" on renal effects of caffeine 69
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 67
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 61
[AVP: a new target in the treatment of chronic kidney disease?] 60
Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients 60
#4500 IMPLEMENTATION OF A NEW GENERATION DIGITAL STETHOSCOPE FOR ARTERIOVENOUS FISTULA MONITORING IN HEMODIALYSIS PATIENTS 59
LOW CIRCULATING LEVELS OF CARDIO-REGULATORY MIRNAS PREDICT WORSE OUTCOMES IN HEMODIALYSIS PATIENTS 59
Erratum: Exercise in patients on dialysis: A multicenter, randomized clinical trial (Journal of the American Society of Nephrology (2017) 28 (1259–1268) DOI: 10.1681/ASN.2016030378) 59
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide 58
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients 57
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease 55
Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health 55
Renal denervation for resistant hypertension 54
[Neutrophil gelatinase-associated lipocalin (NGAL): a biomarker beyond the confines of nephrology] 54
Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease 54
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 52
Erythropoietin and its lost receptor 51
Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy 51
MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients: A Pilot Study 50
Retarding progression of chronic kidney disease in autosomal dominant polycystic kidney disease with metformin and other therapies: An update of new insights 50
Evaluation of arteriovenous fistula for hemodialysis with a new generation digital stethoscope: a pilot study 49
Alterations of lipid metabolism in chronic nephropathies: Mechanisms, diagnosis and treatment 49
Aldosterone antagonists for preventing the progression of chronic kidney disease 49
Aquaretic-induced apoptosis: A cure or a curse? 48
P1422CATHEPSIN-K IS A POWERFUL DIAGNOSTIC BIOMARKER IN PARATHYROIDECTOMIZED DIALYSIS PATIENTS 48
Very low urinary marinobufagenin excretion reflects a high risk of disease progression in non-advanced CKD 46
Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all 46
Glitazones in chronic kidney disease: Potential and concerns 46
[Italian adaptation of the European Renal Best Practice (ERBP) guideline on kidney donor and recipient evaluation and perioperative care] 46
Nephrosclerosis impacts time trajectory of renal function and outcomes in elderly individuals with chronic kidney disease 46
Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors 45
New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases 44
Aquaretic agents: What's beyond the treatment of hyponatremia? 44
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 44
Development of a Wearable Device for Arteriovenous Fistula Monitoring 43
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools 43
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage 42
Acquisition of optical coherence tomography angiography metrics during hemodialysis procedures: A pilot study 42
Immunosuppressive Therapy, Puberty and Growth Outcomes in Pediatric Kidney Transplant Recipients: A Pragmatic Review 41
A portable easy-to-use triboelectric sensor for arteriovenous fistula monitoring in dialysis patients 41
Dialysis and the Elderly: An Underestimated Problem 41
Acute cardiovascular complications of hemodialysis 41
Genomic damage in endothelial progenitor cells from uremic patients 41
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients 41
P1417ALTERED CATHEPSIN-K LEVELS REFLECT SEVERITY OF MINERAL BONE DISEASE AND INFLAMMATION IN CHRONIC HEMODIALYSIS PATIENTS 41
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 40
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 40
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 40
Physical performance and clinical outcomes in dialysis patients: a secondary analysis of the EXCITE trial 39
Neutrophil Gelatinase-associated Lipocalin in the Cardio–Renal Axis – Pathogenic Factor or Just a Risk Biomarker? 39
[The future of the European nephrology belongs to the young: the Young Nephrologists' Platform] 39
Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients 39
Study designs adopted in epidemiology of chronic diseases 39
#4524 TRIBOELECTRIC EVALUATION OF ARTERIOVENOUS FISTULA FOR HAEMODIALYSIS: A PILOT STUDY 38
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 38
Caffeine and the kidney: What evidence right now? 38
Baroreflex stimulation for treating resistant hypertension: Ready for the prime-time? 38
The aging kidney revisited: A systematic review 38
[Erythropoietin: pleiotropic actions] 38
Childhood Obesity: Insight into Kidney Involvement 37
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 37
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 37
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients 37
Good-quality research in rare diseases: trials and tribulations 37
Oxidative stress and kidney function: a brief update 37
Fitness for entering a simple exercise program and mortality: a study corollary to the exercise introduction to enhance performance in dialysis (EXCITE) trial. 36
A new therapy for kidney injury: regeneration 36
Delirium accompanies kidney dysfunction in hospitalized elderly patients 36
Malnutrition in the elderly patient on dialysis 35
Biotic Supplements for Renal Patients: A Systematic Review and Meta-Analysis 35
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 35
Physical excercise programs in CKD: lights, shades and perspectives: a position paper of the “Physical Exercise in CKD Study Group” of the Italian Society of Nephrology 35
Serum creatinine and the search for new biomarkers of acute kidney injury (AKI): The story continues 35
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale 35
OCT angiography metrics predict intradialytic hypotension episodes in chronic hemodialysis patients: a pilot, prospective study 35
Hyperkalemia in CKD: an overview of available therapeutic strategies 35
Decreased Cathepsin-K Mirrors the Severity of Subclinical Atherosclerosis in Kidney Transplant Recipients 34
Potential Pathogenetic Role of the D313Y Mutation in the GLA Gene in Anderson Fabry Disease: Two Case Reports 34
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization 34
Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 34
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 34
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis 34
Nonpharmacological therapies for uncontrolled hypertension 33
Both IL-1β and TNF-α regulate NGAL expression in polymorphonuclear granulocytes of chronic hemodialysis patients 33
Renal complications in oncohematologic patients 33
Smoking habit as a risk amplifier in chronic kidney disease patients 33
Study designs adopted in epidemiology of chronic diseases 33
Circulating miRNA 122-5p Expression Predicts Mortality and Cardiovascular Events in Chronic Hemodialysis Patients: A Multicentric, Pilot, Prospective Study 32
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R) 32
From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology 32
Pulmonary hypertension: A neglected risk condition in renal patients? 32
Utility of Blood Flow/Resistance Index Ratio (Qx) as a Marker of Stenosis and Future Thrombotic Events in Native Arteriovenous Fistulas 32
The Role of prEoperative ultraSonography on patenCy of native arteriovenoUs accEss: RESCUE study protocol 32
Renal biopsy in 2015 - From epidemiology to evidence-based indications 31
COVID-19 clinical manifestations and treatment strategies among solid-organ recipients: A systematic review of cases 30
Totale 4.468
Categoria #
all - tutte 86.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 8 7 12 6 5 7 2 1
2021/2022452 17 1 3 86 59 5 18 120 29 25 85 4
2022/2023869 344 99 17 38 54 43 13 55 100 28 57 21
2023/2024533 74 41 43 39 42 89 25 47 25 45 28 35
2024/20252.115 312 70 54 132 145 349 49 63 240 62 231 408
2025/20262.713 252 582 627 775 477 0 0 0 0 0 0 0
Totale 7.044